Ipilimumab vs Lansoprazole
Ipilimumab vs Lansoprazole: Overview
This comparison examines the pharmacological differences between Ipilimumab and Lansoprazole.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Lansoprazole: Proton pump inhibitor.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Lansoprazole — 1.5 hours.
Chemical Properties
Molecular Formula: Lansoprazole — C16H14F3N3O2S.
Molecular Weight: Lansoprazole — 369.3620 g/mol.
Type: Ipilimumab — Antibody; Lansoprazole — Small molecule.